NT5E and Lipedema: Priglinger et al. also showed no difference in the MSC markers CD90, CD73 and CD105, as well as in the proliferation rate of ASCs isolated from SVF of lipedema patients compared to healthy patients [29], which is consistent with our findings on lipedema ASCs isolated from SVF-T but which contradicts the data published by Bauer et al. showing a significant increase in proliferation in lipedema ASCs at day 14 compared to non-lipedema ASCs [39].